期刊文献+

口服多剂量茶碱个体化给药方案的改良设计

Modification and Design of Individual Regimen for Oral Multi-dose of Theophylline
原文传递
导出
摘要 目的:基于Excel表格程序设计茶碱个体化给药方案。方法:茶碱具有一室模型一级消除特征,根据群体药动学参数和患者个体的病理生理状态,设计个体化给药方案。结果:只需输入患者的年龄、身高、体重和病理生理状态及初始给药剂量和给药间隔,通过逻辑判断,程序即可自动快速计算出相应的稳态血药浓度值,通过改变给药剂量和给药间隔,观察稳态血药浓度变化范围,直至给药方案可行;也可求解任一时间点血药浓度。结论:根据茶碱群体药动学参数和患者的病理生理特点,可利用Excel表格程序设计茶碱个体化给药方案,方法简单、可靠、直观、易学。 OBJECTIVE: To design individual regimen of theophylline based on Excel program. METHODS: Theophylline clearance can be explained by single-compartment model with first-order elimination. Individual regimen can be designed according to population pharmacokinetic parameters and individual pathopbysiologic status. RESULTS: Once the patients' age, body height (BH), body weight(BW), pathophysiologic status, initial drug dosage and dosing interval were inputted, the data was stored to different domain by logic test, the initial steady blood drug level was calculated automatically and immediately. The change range of steady blood drug level was observed by changing dose and dosing interval until regime was feasible. The blood concentration of drug at any time can also be obtained rapidly after inputting the time. CONCLUSIONS: Individual regimen of theophylline can be designed by using Excel according to population pharmacokinetic parameters and pathophysiological characteristics of patients. It is simple, reliable, direct and easy to learn.
出处 《中国药房》 CAS CSCD 2012年第10期940-942,共3页 China Pharmacy
基金 广东省医学科研课题(B2008151)
关键词 计算机辅助设计 单室模型 茶碱 Excel表格程序 Computer-assisted design Single-compartment model Theophylline Excel program
作者简介 副主任药师。研究方向:临床药学。电话:020—36654464。E—mail:yuanjin-888@163.com
  • 相关文献

参考文献13

  • 1Barnes PJ. Theophylline for COPD[J]. Thorax, 2006, 61 (9):742.
  • 2Korematsu S, Miyahara H, Nagakura T, et al.Theophyl- line-associated seizures and their clinical characterizations [J].Pediatr Int, 2008,50 ( 1 ) : 95.
  • 3Watanabe S, Yamakami J, Tsuchiya M, et al.Anti-inflam- matory effect of theophylline in rats and its involvement of the glucocorticoid-glucocorticoid receptor system[J].J Pharmacol Sci, 2008,106(4) : 566.
  • 4Ward AJM, McKenniff M, Evans JM, et aLTheophylline: an immunomodulatory in asthma?[J].Am Rev Respir Dis, 1993,147(3) :518.
  • 5Cushley M J, Tatterfield AE, Holgate ST.Inhaled adenosine and guanosine on airway resistance in normal and asth- matic subjects [J].Br J Clin Pharmacol, 1983,15 (2) : 161.
  • 6Upton RA.Pharmacokinetic interactions between theophyl- line and other medication (Part I ) [J].Clin Pharmacoki- net, 1991,20(1) :66.
  • 7袁进,吴新荣,浦金辉.基于Excel函数设计茶碱口服多剂量个体化给药方案[J].中国药房,2009,20(26):2073-2075. 被引量:4
  • 8彭斌.临床药动学[M].长沙:湖南科学技术出版社,1999:260、267.
  • 9黄守坚,陈汝筑,黎明涛.茶碱的个体化给药[J].新医学,2004,35(4):241-242. 被引量:4
  • 10李珍,陈刚.住院病人茶碱群体药物动力学NONMEM法分析[J].中国药理学报,1994,15(3):267-270. 被引量:6

二级参考文献16

  • 1孙丽萍,李君荣,张德厚,李坚.合并使用喹诺酮类药物时计算机指导氨茶碱的个体化给药[J].临床荟萃,2004,19(16):901-903. 被引量:3
  • 2于峰,牛桂田,陈冰.三点法求算口服氨茶碱药代动力学参数[J].医学研究生学报,2004,17(11):1053-1054. 被引量:5
  • 3马全华,刘绪琢,王美玲.三点法监测氨茶碱血药浓度求算药动学参数[J].中国药学杂志,1995,30(8):482-484. 被引量:1
  • 4Upton RA.Pharmacokinetic interactions between theophylline and other medication (Part Ⅰ)[J] . Clin Pharmacokinet, 1991,20(1) : 66.
  • 5Loi CM, Parker BM, Cusack BJ, et al. Individual and combined effects of cimetidine and ciprofloxacin on theophylline metabolism in male nonsmokers[J ]. Br J Clin Pharmacol, 1993,36(3) : 195.
  • 6李珍,Chin J Hosp Pharm,1992年,12卷,291页
  • 7EASON J,MARKOWE H L J.Aminophylline toxicity--how many hospital asthma deaths does it cause ?[J].Respiratory Medicine,1989,83(3):219-226.
  • 8RICK T.Theophylline dose[EB/OL].http://www.rxlist.com/cgi/generic/theosr-cp.htm,2004.
  • 9孙丽萍 蔡映云.微机在抗哮喘药物研究中的应用[A].见:李明华.哮喘病药物治疗学[M].北京:人民卫生出版社,2001.422-430.
  • 10周怀悟 孙伟民.临床计量医学[M].上海:上海医科大学出版社,1999.88-94.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部